Amanote Research
Register
Sign In
The Discovery of New 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitors by Common Feature Pharmacophore Modeling and Virtual Screening
doi 10.1021/jm0600794.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery of Novel NAMPT Inhibitors Based on Pharmacophore Modeling and Virtual Screening Techniques
Combinatorial Chemistry and High Throughput Screening
Medicine
Organic Chemistry
Drug Discovery
Computer Science Applications
Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(Adamant-2-Yl) Acetamide 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
Identification of New Human Malaria Parasite Plasmodium Falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening
Drug Discovery by Integration of Pharmacophore Modeling, Virtual Screening and Biological Evaluation by Means of Bioinformatics Resources
Discovery of New Butyrylcholinesterase Inhibitors via Structure-Based Virtual Screening
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
2-(S)-Phenethylaminothiazolones as Potent, Orally Efficacious Inhibitors of 11b-Hydroxysteriod Dehydrogenase Type 1
Identification of Novel Acetylcholinesterase Inhibitors Designed by Pharmacophore-Based Virtual Screening, Molecular Docking and Bioassay
Scientific Reports
Multidisciplinary
Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
Genomics and Informatics
Evolution
Ecology
Genetics
Systematics
Health Informatics
Behavior
11?-Hydroxysteroid Dehydrogenase Type 1 in Obesity and Type 2 Diabetes
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
